Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Natus Medical Inc (NTUS)

Natus Medical Inc (NTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Natus Medical Inc 3150 PLEASANT VIEW ROAD MIDDLETON WI 53562 USA

www.natus.com P: 608-829-8500

Description:

Natus Medical Incorporated is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories.

Key Statistics

Overview:

Market Capitalization, $K 1,133,911
Enterprise Value, $K 1,133,827
Shares Outstanding, K 34,581
Annual Sales, $ 473,440 K
Annual Net Income, $ 13,180 K
Last Quarter Sales, $ 119,790 K
Last Quarter Net Income, $ 1,900 K
60-Month Beta 0.22
% of Insider Shareholders 1.20%
% of Institutional Shareholders 92.35%
Float, K 34,166
% Float 98.80%
Short Volume Ratio 0.45

Growth:

1-Year Return 34.48%
3-Year Return 20.25%
5-Year Return -6.36%
5-Year Revenue Growth 23.97%
5-Year Earnings Growth -25.93%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.22 on 05/05/22
Next Earnings Date 08/04/22
Earnings Per Share ttm 1.26
EPS Growth vs. Prev Qtr -53.19%
EPS Growth vs. Prev Year 37.50%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

NTUS Ratios

Ratio
Price/Earnings ttm 25.95
Price/Earnings forward 22.89
Price/Earnings to Growth N/A
Return-on-Equity % 10.15%
Return-on-Assets % 7.65%
Profit Margin % 2.78%
Debt/Equity 0.00
Price/Sales 2.39
Price/Cash Flow 16.34
Price/Book 2.65
Book Value/Share 12.46
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar